AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2010
Jan 14, 2010
32566_dirs_2010-01-14_3517ea1d-f51a-4072-a6e8-3954f6379301.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2009-12-03
Reporting Person: MARSH RICHARD M (V.P., General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-10-30 | Common Stock | G | 300 | — | Disposed | 18678 | Direct |
| 2009-12-03 | Common Stock | G | 4200 | — | Disposed | 14808 | Direct |
| 2010-01-12 | Common Stock | M | 9726 | $7.27 | Acquired | 24534 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-01-12 | Incentive Stock Option (right to buy) | $7.27 | M | 9726 | Disposed | 2015-09-14 | Common Stock (9726) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8000 | Indirect |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27